Literature DB >> 21412154

Recurrent nasopharyngeal carcinoma: surgical salvage vs. additional chemoradiation.

William I Wei1, Dora L W Kwong.   

Abstract

PURPOSE OF REVIEW: The primary treatment modality of nasopharyngeal carcinoma (NPC) is radiation or chemoradiation. With the application of conformal radiation and appropriate chemotherapeutic agents, there was marked improvement in the outcome. Despite this, a small number of patients still develop residual or recurrent disease either in the neck or at the primary site. In recent years there are many developments in the disciplines of surgery, radiation and medical oncology which are applicable for the management of residual or recurrent NPC. It is timely to review the applicability and efficacy of the various therapeutic options. RECENT
FINDINGS: The theme of the literature review included the management of these recurrent or residual diseases in the neck or nasopharynx with open or endoscopic or robot-assisted surgical approaches. The application of radiation techniques such as intensity modulated radiotherapy, stereotactic radiation and brachytherapy was also included. The use of chemotherapy and targeted agents is also reviewed.
SUMMARY: In general, the size, extent and location of the residual or recurrent NPC together with the biological behaviour of the tumour determine the optimal therapy. The surgical and clinical oncological expertise applied optimally will give the best outcome.

Entities:  

Mesh:

Year:  2011        PMID: 21412154     DOI: 10.1097/MOO.0b013e328344a599

Source DB:  PubMed          Journal:  Curr Opin Otolaryngol Head Neck Surg        ISSN: 1068-9508            Impact factor:   2.064


  9 in total

1.  Hyperfractionation compared to standard fractionation in intensity-modulated radiation therapy for patients with locally advanced recurrent nasopharyngeal carcinoma.

Authors:  Victor H F Lee; Dora L W Kwong; To-Wai Leung; Sherry C Y Ng; Ka-On Lam; Chi-Chung Tong; Chun-Kin Sze
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-10-13       Impact factor: 2.503

2.  A nomogram for predicting survival of nasopharyngeal carcinoma patients with metachronous metastasis.

Authors:  Zixun Zeng; Lujun Shen; Yue Wang; Feng Shi; Chen Chen; Ming Wu; Yutong Bai; Changchuan Pan; Yunfei Xia; Peihong Wu; Wang Li
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

3.  Metronomic oral cyclosphosphamide as third-line systemic treatment or beyond in patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma.

Authors:  Victor H F Lee; Dora L W Kwong; Ka-On Lam; Yu-Ching Lai; Yun Li; Chi-Chung Tong; Patty P Y Ho; Wing-Lok Chan; Lai-San Wong; Dennis K C Leung; Sum-Yin Chan; Fong-Ting Chan; To-Wai Leung; Anne W M Lee
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

4.  Pre-emptive and therapeutic adoptive immunotherapy for nasopharyngeal carcinoma: Phenotype and effector function of T cells impact on clinical response.

Authors:  Corey Smith; Victor Lee; Andrea Schuessler; Leone Beagley; Sweera Rehan; Janice Tsang; Vivian Li; Randal Tiu; David Smith; Michelle A Neller; Katherine K Matthews; Emma Gostick; David A Price; Jacqueline Burrows; Glen M Boyle; Daniel Chua; Benedict Panizza; Sandro V Porceddu; John Nicholls; Dora Kwong; Rajiv Khanna
Journal:  Oncoimmunology       Date:  2017-01-04       Impact factor: 8.110

5.  Clinical Characteristics and Predictive Outcomes of Recurrent Nasopharyngeal Carcinoma-A Lingering Pitfall of the Long Latency.

Authors:  Yung-Hsuan Chen; Sheng-Dean Luo; Shao-Chun Wu; Ching-Nung Wu; Tai-Jan Chiu; Yu-Ming Wang; Yao-Hsu Yang; Wei-Chih Chen
Journal:  Cancers (Basel)       Date:  2022-08-04       Impact factor: 6.575

Review 6.  Treatment of Recurrent Nasopharyngeal Carcinoma: A Sequential Challenge.

Authors:  Zhouying Peng; Yumin Wang; Ruohao Fan; Kelei Gao; Shumin Xie; Fengjun Wang; Junyi Zhang; Hua Zhang; Yuxiang He; Zhihai Xie; Weihong Jiang
Journal:  Cancers (Basel)       Date:  2022-08-25       Impact factor: 6.575

Review 7.  Emerging treatment options for nasopharyngeal carcinoma.

Authors:  Lu Zhang; Qiu-Yan Chen; Huai Liu; Lin-Quan Tang; Hai-Qiang Mai
Journal:  Drug Des Devel Ther       Date:  2013-02-01       Impact factor: 4.162

Review 8.  Current treatment options for local residual nasopharyngeal carcinoma.

Authors:  S D Stoker; J N A van Diessen; J P de Boer; B Karakullukcu; C R Leemans; I B Tan
Journal:  Curr Treat Options Oncol       Date:  2013-12

9.  Intensity-modulated carbon-ion radiation therapy versus intensity-modulated photon-based radiation therapy in locally recurrent nasopharyngeal carcinoma: a dosimetric comparison.

Authors:  Lei Wang; Jiyi Hu; Xiaoli Liu; Weiwei Wang; Lin Kong; Jiade J Lu
Journal:  Cancer Manag Res       Date:  2019-08-16       Impact factor: 3.989

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.